Tavlesse® (fostamatinib)
Mechanism of Action
To view the Prescribing Information and Adverse Event Reporting Information, please click the links below:
Tavlesse® (fostamatinib) 100-mg film-coated tablets – click here
Tavlesse® (fostamatinib) 150-mg film-coated tablets – click here
UK-TVLS-2600009 | Date of Preparation: June 2026